- MM&M >
- Channel >
- Pharmaceutical >
- Fusilev
Fusilev
FUSILEV(TM) is indicated after high-dose methotrexate therapy in patients with osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination or inadvertent overdose of folic acid antagonists.
Register for free with MM&M
Registration acknowledges the Terms and Conditions and Privacy Policy
Already have an account?
Log in now »FORGET YOUR PASSWORD?
Enter your MM&M registration email address to receive a password reset link.
NEW PASSWORD SENT
Already have an account?
Log in now »LINK YOUR ACCOUNT
LINK YOUR ACCOUNTS
It looks like we already have a MM&M account for:
Please confirm the information BELOW to link this account to your account
By registering you agree with our Terms and Conditions and Privacy Policy.
« CANCEL AND GO BACKNot you? Create an account for free »
ALMOST DONE
Almost Done
Please confirm the information BELOW before Signing In
By registering you agree with our Terms and Conditions and Privacy Policy.
« CANCEL AND GO BACK
